𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Current status of anti-angiogenic agents in the treatment of ovarian carcinoma

✍ Scribed by Alfonso Sánchez-Muñoz; Elisabeth Pérez-Ruiz; César Mendiola Fernández; Emilio Alba Conejo; Antonio González-Martín

Book ID
107597548
Publisher
Springer Milan
Year
2009
Tongue
Spanish
Weight
298 KB
Volume
11
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant 32P in the treatment of ovarian
Adjuvant 32P in the treatment of ovarian carcinoma
✍ Kellie S. Condra; William M. Mendenhall; Linda S. Morgan; Robert B. Marcus Jr. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

The purpose of this study was to evaluate the efficacy of adjuvant 32 P for patients with high-risk, early-stage ovarian carcinoma. Twenty-five patients underwent apparent complete resection followed by 32 P (15 mCi) at the University of Florida between 1976 and 1993. Minimum and median follow-up ti